Jubilant Ingrevia to invest ₹600 crore annually for expansion
after close1 source ↓written by the desknot a recommendation
- annually to expand
- ₹500-600 crore
- investment
- ₹2,000 crore
- in revenue
- 20-25% annual growth
Jubilant Ingrevia plans to invest ₹500-600 crore annually to expand production of Vitamin B3 and Vitamin B4. This follows a ₹2,000 crore investment over the last three years. The firm aims for 20-25% annual growth in revenue and EBITDA by FY27, enhancing operations at Bharuch and Gajraula.
Not investment advice. For informational purposes only.